Design Therapeutics Inc. (DSGN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Design Therapeutics Inc.

    NASDAQ: DSGN · Real-Time Price · USD
    6.09
    0.08 (1.25%)
    At close: Oct 03, 2025, 3:19 PM

    Design Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 22.56M 21.2M 26.5M 298.57M
    Short-Term Investments
    		 222.91M 260.6M 303.89M 85.5M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 427K 430K 459K n/a
    Receivables
    		 1.26M 1.43M 1.11M 110K
    Inventory
    		 n/a n/a n/a 1.25M
    Other Current Assets
    		 n/a n/a n/a -1.25M
    Total Current Assets
    		 248.04M 284.58M 335.12M 385.44M
    Property-Plant & Equipment
    		 3.63M 4.63M 5.56M 5.12M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 4.05M 5.06M 6.02M 5.12M
    Total Assets
    		 252.09M 289.64M 341.14M 390.56M
    Account Payables
    		 2.19M 1.94M 3.02M 1.62M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 800K 716K 640K 489K
    Other Current Liabilities
    		 -800K 2.22M 2.93M 533K
    Total Current Liabilities
    		 8.46M 9.62M 10.78M 5.28M
    Long-Term Debt
    		 n/a 2.33M 3.05M 3.14M
    Other Long-Term Liabilities
    		 n/a -2.33M -3.05M -3.14M
    Total Long-Term Liabilities
    		 1.53M 2.33M 3.05M 3.14M
    Total Liabilities
    		 10M 11.96M 13.83M 8.43M
    Total Debt
    		 2.33M 3.05M 3.69M 3.63M
    Book Value
    		 242.1M 277.69M 327.31M 382.13M
    Book Value Per Share
    		 4.28 4.96 5.88 8.32
    Common Stock
    		 6K 6K 6K 6K
    Retained Earnings
    		 -227.21M -177.63M -110.76M -47.46M
    Comprehensive Income
    		 475K 62K -3.36M -244K
    Shareholders Equity
    		 242.1M 277.69M 327.31M 382.13M
    Total Investments
    		 222.91M 260.6M 303.89M 85.5M

    Add to Watchlist